| Report ID |
71284 |
| Drug Identification Number |
02354586 |
| Brand name |
RENVELA |
| Common or Proper name |
Renvela |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
Sevelamer Carbonate |
| Strength(s) |
800MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
180 |
| ATC code |
V03AE |
| ATC description |
ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage |
Delay in shipping of the drug. |
| Anticipated start date |
|
| Actual start date |
2019-01-03 |
| Estimated end date |
2019-01-11 |
| Actual end date |
2019-01-09 |
| Shortage status |
Resolved |
| Updated date |
2019-01-10 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
